CVS INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that CVS Health Corporation Investors with Substantial Losses Have Opportunity to Lead Case
CVSCVS Health(CVS) GlobeNewswire News Room·2024-07-27 21:24

SAN DIEGO, July 27, 2024 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of CVS Health Corporation (NYSE: CVS) securities between May 3, 2023 and April 30, 2024, both dates inclusive (the “Class Period”), have until September 10, 2024 to seek appointment as lead plaintiff of the CVS class action lawsuit. Captioned Nixon v. CVS Health Corporation, No. 24-cv-05303 (S.D.N.Y.), the CVS class action lawsuit charges CVS as well as certain of CVS’s top cu ...